A comparative study of a new once-a-day theophylline preparation with Theo-Dur given twice daily. 1993

M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
Allergy and Asthma Medical Group and Research Center, San Diego, California 92123.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017060 Patient Satisfaction The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial. Satisfaction, Patient

Related Publications

M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
September 1986, Ugeskrift for laeger,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
November 1987, Journal of clinical pharmacology,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
May 1988, International journal of clinical pharmacology, therapy, and toxicology,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
December 1985, The American journal of medicine,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
June 1984, Revista de medicina de la Universidad de Navarra,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
April 1994, International journal of clinical pharmacology and therapeutics,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
May 1987, Fortschritte der Medizin,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
July 1988, The American journal of medicine,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
June 2001, Asian Pacific journal of allergy and immunology,
M J Welch, and J P Kemp, and N K Ostrom, and H A Orgel, and E O Meltzer, and L Romero, and N Klinger, and S McCarville, and L I Harrison
October 1987, International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!